The ten biggest drug makers spent more than $50bn on research in 2008. For the same amount, they could own the entire US biotech industry save the five biggest companies. It might be a better use of their cash.Sign up to read the rest of this subscriber-only content, or if you are already a member please sign in here.
Forgotten your password? Get a password reminder.
This Views Flash will shortly be followed by a Considered View